Wikipedia -WSS

Wikipedia

author：explore 2025-09-29 01:37:08 - browse：6

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Was Amgen transparent enough on FDA's concern on cancer drug?

WSS

Newly revealed memo details efforts to keep Trump in power following election loss

Analysis of telehealth claims data suggest service duplication

Timeline: Special counsel's investigation into Trump's handling of classified documents

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Maui funeral service workers on devastation of fires: 'I'm in shock'

Histogen: Failed biotech offers rare public look inside

knowledge

Wikipedia

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Liquid biopsy for lung cancer is launched by Delfi

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Chemotherapy drug shortage eases slightly but still widespread

Heart attack and stroke risk calculators need revising

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Novavax promises a turnaround & Lilly roils the obesity market

FDA rejects Alnylam's heart disease treatment over insufficient data

Heart attack and stroke risk calculators need revising

FDA authorizes Novavax’s updated Covid

knowledge

The future of health care in the House

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Covid's long

CDC overhauls leadership of center that led response to Covid

Colorectal cancer study finds potential in overlooked immune cell

TB outbreak tied to bone grafts underscores testing shortcomings

Wikipedia

Wikipedia

focus

explore